KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Precigen (PGEN) EBT (2016 - 2025)

Precigen (PGEN) has disclosed EBT for 14 consecutive years, with -$146.3 million as the latest value for Q3 2025.

  • On a quarterly basis, EBT fell 510.63% to -$146.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$247.0 million, a 74.4% decrease, with the full-year FY2024 number at -$128.0 million, down 32.86% from a year prior.
  • EBT was -$146.3 million for Q3 2025 at Precigen, down from -$26.6 million in the prior quarter.
  • In the past five years, EBT ranged from a high of -$7.7 million in Q3 2022 to a low of -$146.3 million in Q3 2025.
  • A 5-year average of -$34.5 million and a median of -$24.0 million in 2024 define the central range for EBT.
  • Peak YoY movement for EBT: skyrocketed 70.83% in 2022, then crashed 510.63% in 2025.
  • Precigen's EBT stood at -$39.1 million in 2021, then soared by 43.25% to -$22.2 million in 2022, then plummeted by 50.61% to -$33.4 million in 2023, then surged by 40.66% to -$19.8 million in 2024, then crashed by 638.59% to -$146.3 million in 2025.
  • Per Business Quant, the three most recent readings for PGEN's EBT are -$146.3 million (Q3 2025), -$26.6 million (Q2 2025), and -$54.2 million (Q1 2025).